Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Operating expenses:
Research and development expenses	$ 1,886,934	$ 168,606	$ 2,916,937	$ 369,744
General and administrative expenses	2,383,972	398,425	6,289,848	934,226
Total operating expenses	4,270,906	567,031	9,206,785	1,303,970
Loss from operations	(4,270,906)	(567,031)	(9,206,785)	(1,303,970)
Other income (expense):
Gain on bargain purchase	209,449	0	11,939,331	0
Interest income	175,605	4	198,907	10
Interest expense	0	(804)	(606)	(1,763)
Net income (loss)	(3,885,852)	(567,831)	2,930,847	(1,305,723)
Comprehensive income (loss)	$ (3,885,852)	$ (567,831)	$ 2,930,847	$ (1,305,723)
Per share information:
Net income (loss) per share, basic (in dollars per share)	$ (0.75)	$ (0.17)	$ 0.66	$ (0.41)
Net income (loss) per share, diluted (in dollars per share)	$ (0.75)	$ (0.17)	$ 0.52	$ (0.41)
Weighted average common shares outstanding, basic (in shares)	5,175,837	3,338,214	4,466,025	3,170,804
Weighted average common shares outstanding, diluted (in shares)	5,175,837	3,338,214	5,677,360	3,170,804